Meeting
2022 ASCO Annual Meeting
Screening for high frequency malignant disease (SHIELD).
Authors
HA NGUYEN
Guardant Health, Inc., Redwood City, CA
HA NGUYEN , Victoria M. Raymond , Erika Vento-Gaudens , Enrique Marino , Kathryn Lang , Craig Eagle
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Care Delivery and Regulatory Policy
Track
Care Delivery and Quality Care
Sub Track
Clinical Research Design
Clinical Trial Registration Number
NCT05117840
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr TPS1602)
DOI
10.1200/JCO.2022.40.16_suppl.TPS1602
Abstract #
TPS1602
Poster Bd #
192a
Abstract Disclosures
Similar Posters
First Author: HA Nguyen
Poster
2024 ASCO Quality Care Symposium
Cross-sectional study of assessment of lung cancer (LC) screening awareness in an underserved community in the Bronx, New York.
First Author: Nehemias Antonio Guevara Rodriguez
First Author: Lakshmi Kolandra
Poster
2023 ASCO Annual Meeting
National lung cancer screening rates among women veterans within the Veterans’ Health Administration.
First Author: Jennifer Bail